Show simple item record

dc.contributor.authorMiller, Tyler E
dc.contributor.authorLareau, Caleb A
dc.contributor.authorVerga, Julia A
dc.contributor.authorDePasquale, Erica AK
dc.contributor.authorLiu, Vincent
dc.contributor.authorSsozi, Daniel
dc.contributor.authorSandor, Katalin
dc.contributor.authorYin, Yajie
dc.contributor.authorLudwig, Leif S
dc.contributor.authorEl Farran, Chadi A
dc.contributor.authorMorgan, Duncan M
dc.contributor.authorSatpathy, Ansuman T
dc.contributor.authorGriffin, Gabriel K
dc.contributor.authorLane, Andrew A
dc.contributor.authorLove, J Christopher
dc.contributor.authorBernstein, Bradley E
dc.contributor.authorSankaran, Vijay G
dc.contributor.authorvan Galen, Peter
dc.date.accessioned2025-11-12T21:30:16Z
dc.date.available2025-11-12T21:30:16Z
dc.date.issued2022-02-24
dc.identifier.urihttps://hdl.handle.net/1721.1/163633
dc.description.abstractThe combination of single-cell transcriptomics with mitochondrial DNA variant detection can be used to establish lineage relationships in primary human cells, but current methods are not scalable to interrogate complex tissues. Here, we combine common 3′ single-cell RNA-sequencing protocols with mitochondrial transcriptome enrichment to increase coverage by more than 50-fold, enabling high-confidence mutation detection. The method successfully identifies skewed immune-cell expansions in primary human clonal hematopoiesis.en_US
dc.language.isoen
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionof10.1038/s41587-022-01210-8en_US
dc.rightsCreative Commons Attribution-Noncommercial-ShareAlikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePubMed Centralen_US
dc.titleMitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populationsen_US
dc.typeArticleen_US
dc.identifier.citationMiller, T.E., Lareau, C.A., Verga, J.A. et al. Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations. Nat Biotechnol 40, 1030–1034 (2022).en_US
dc.contributor.departmentBroad Institute of MIT and Harvarden_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.relation.journalNature Biotechnologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2025-11-12T21:21:44Z
dspace.orderedauthorsMiller, TE; Lareau, CA; Verga, JA; DePasquale, EAK; Liu, V; Ssozi, D; Sandor, K; Yin, Y; Ludwig, LS; El Farran, CA; Morgan, DM; Satpathy, AT; Griffin, GK; Lane, AA; Love, JC; Bernstein, BE; Sankaran, VG; van Galen, Pen_US
dspace.date.submission2025-11-12T21:21:46Z
mit.journal.volume40en_US
mit.journal.issue7en_US
mit.licenseOPEN_ACCESS_POLICY
mit.metadata.statusAuthority Work and Publication Information Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record